LabCorp (NYSE:LH) said Thursday that the Federal Trade Commission had cleared its plan to acquire Genzyme Genetics, a business unit of Genzyme Corp. (NASDAQ: GENZ).

The all-cash deal is valued  $925 million. FTC review of antitrust questions was required.

LabCorp has said it expects to close on or around Dec. 1.

Get the latest news alerts: Follow LTW at Twitter.